What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
The scientist’s investigation covers issues in Transplantation, Internal medicine, Surgery, Gastroenterology and Hematopoietic stem cell transplantation.
The concepts of his Transplantation study are interwoven with issues in Survival rate, Immunology, Bone marrow, Total body irradiation and Fludarabine.
Rainer Storb frequently studies issues relating to Oncology and Internal medicine.
His study looks at the intersection of Surgery and topics like Cumulative incidence with Survival analysis.
His study explores the link between Gastroenterology and topics such as Toxicity that cross with problems in Mycophenolic acid.
His studies in Hematopoietic stem cell transplantation integrate themes in fields like Incidence, Retrospective cohort study, Hazard ratio, Transplantation Conditioning and Comorbidity.
His most cited work include:
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. (1740 citations)
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. (1740 citations)
- Evidence for Circulating Bone Marrow-Derived Endothelial Cells (1589 citations)
What are the main themes of his work throughout his whole career to date?
Rainer Storb mainly focuses on Transplantation, Internal medicine, Immunology, Surgery and Total body irradiation.
His Transplantation research is multidisciplinary, incorporating elements of Immunosuppression, Fludarabine and Bone marrow.
His Internal medicine research includes themes of Gastroenterology and Oncology.
His studies deal with areas such as Haematopoiesis, Stem cell and Peripheral blood mononuclear cell as well as Immunology.
His research brings together the fields of Incidence and Surgery.
The study incorporates disciplines such as Cumulative incidence and Urology in addition to Total body irradiation.
He most often published in these fields:
- Transplantation (86.80%)
- Internal medicine (68.46%)
- Immunology (56.21%)
What were the highlights of his more recent work (between 2012-2021)?
- Transplantation (86.80%)
- Internal medicine (68.46%)
- Hematopoietic stem cell transplantation (38.81%)
In recent papers he was focusing on the following fields of study:
Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Total body irradiation and Immunology are his primary areas of study.
His Transplantation study focuses on Graft-versus-host disease in particular.
His Internal medicine study incorporates themes from Gastroenterology, Surgery and Oncology.
His research investigates the connection with Hematopoietic stem cell transplantation and areas like Comorbidity which intersect with concerns in Nonrelapse mortality.
Rainer Storb combines subjects such as Radioimmunotherapy, Conditioning, Regimen, Myelodysplastic syndromes and CD20 with his study of Total body irradiation.
His research investigates the link between Immunology and topics such as Dog leukocyte antigen that cross with problems in Methotrexate.
Between 2012 and 2021, his most popular works were:
- Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation (217 citations)
- Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation (156 citations)
- Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation. (127 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Rainer Storb focuses on Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Surgery and Immunology.
A large part of his Transplantation studies is devoted to Graft-versus-host disease.
His Internal medicine research incorporates elements of Gastroenterology and Oncology.
His research in Hematopoietic stem cell transplantation intersects with topics in Proportional hazards model, Radioimmunotherapy, Risk of mortality and Survival analysis.
His biological study spans a wide range of topics, including Young adult, Bone marrow failure, Cohort and Minimal residual disease.
His Immunology research includes elements of Cytotoxic T cell and Hematopoietic cell, Haematopoiesis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
